p130 Is Dispensable in Peripheral T Lymphocytes: Evidence for Functional Compensation by p107 and pRB

REFERENCES

• Aagaard, L., J. Lukas, J. Bartkova, A. A. Kjerulff, M. Strauss, and J. Bartek 1995. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct subsets of human cancer cell lines. Int. J. Cancer 61: 115–120.
   PubMed Web of Science ®Google Scholar
• Almasan, A., R. Kelly, E. Lee, A. Bradley, W. Li, J. Bertino, and G. Wahl 1995. Deficiency of the retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92: 5436–5440.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, P. Guldberg, J. Alsner, A. Kirkin, J. Zeuthen, and J. Bartek 1996. The p16-cyclinD/cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 56: 5475–5483.
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9: 1340–1353.
   PubMedGoogle Scholar
• Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards 1994. E2F-4, a new member of the E2F family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8: 2680–2690.
   PubMed Web of Science ®Google Scholar
• Braun, T., and H. Arnold 1996. myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15: 310–318.
   PubMed Web of Science ®Google Scholar
• Cao, L., B. Faha, M. Dembski, L. H. Tsai, E. Harlow, and N. Dyson 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176–179.
   PubMedGoogle Scholar
• Chen, G., C. T. Guy, H. W. Chen, N. Hu, E. Y. Lee, and W. H. Lee 1996. Molecular cloning and developmental expression of mouse p130, a member of the retinoblastoma gene family. J. Biol. Chem. 271: 9567–9572.
   PubMedGoogle Scholar
• Chen, J., J. Gorman, V. Stewart, B. Williams, T. Jacks, and F. W. Alt 1993. Generation of normal lymphocyte populations of Rb-deficient ES cells: analysis of gene function by RAG-2-deficient blastocyst complementation. Curr. Biol. 3: 405–413.
   PubMedGoogle Scholar
• Chen, S., and E. Paucha 1990. Identification of a region of simian virus 40 large T antigen required for cell transformation. J. Virol. 64: 3350–3357.
   PubMed Web of Science ®Google Scholar
• Chittenden, T., D. M. Livingston, and J. A. DeCaprio 1993. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13: 3975–3983.
   PubMedGoogle Scholar
• Christensen, J., and M. Imperiale 1995. Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2-like domain of simian virus 40 large T antigen. J. Virol. 69: 3945–3948.
   PubMedGoogle Scholar
• Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330.
   PubMed Web of Science ®Google Scholar
• Claudio, P. P., A. De Luca, C. M. Howard, A. Baldi, E. J. Firpo, A. Koff, M. G. Paggi, and A. Giordano 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 56: 2003–2008.
   PubMed Web of Science ®Google Scholar
• Claudio, P. P., C. M. Howard, A. Baldi, A. De Luca, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54: 5556–5560.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208: 31–61.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D., M. Lee, G. Hannon, G. Mulligan, R. Bronson, N. Dyson, E. Harlow, D. Beach, R. Weinberg, and T. Jacks 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10: 1633–1644.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7: 2392–2404.
   PubMed Web of Science ®Google Scholar
• Corbeil, H. B., P. Whyte, and P. E. Branton 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11: 909–920.
   PubMedGoogle Scholar
• Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355–361.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., T. Kowalik, and J. Nevins 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215–4224.
   PubMed Web of Science ®Google Scholar
• Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin 1993. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J. Virol. 66: 7641–7647.
   Google Scholar
• Ernst, D. N., D. Weigle, D. J. Noonan, D. N. McQuitty, and M. V. Hobbs 1993. The age-associated increase in IFN synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11 and MEL-14 expression. J. Immunol. 151: 575–581.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingston 1991. Molecular cloning, chromosomal mapping and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66: 1155–1164.
   PubMed Web of Science ®Google Scholar
• Ginsberg, D., G. Vairo, T. Chittenden, Z. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8: 2665–2679.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., D. Demetrick, and D. Beach 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7: 2378–2391.
   PubMed Web of Science ®Google Scholar
• He, J., J. Olson, and C. James 1995. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55: 4833–4836.
   PubMed Web of Science ®Google Scholar
• Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337–350.
   PubMed Web of Science ®Google Scholar
• Herrera, R. E., V. P. Sah, B. O. Williams, R. A. Weinberg, and T. Jacks 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16: 2402–2407.
   PubMedGoogle Scholar
• Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. van’t Veer, and R. Bernards 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15: 3082–3089.
   PubMedGoogle Scholar
• Huet, X., A. Rech, A. Plet, and J. Blanchard 1996. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. Biol. 16: 3789–3798.
   PubMedGoogle Scholar
• Hurford, R. K., D. Cobrinik, M. Lee, and N. Dyson 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11: 1447–1463.
   PubMed Web of Science ®Google Scholar
• Ikeda, M., L. Jakoi, and J. Nevins 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93: 3215–3220.
   PubMedGoogle Scholar
• Jacks, T., A. Fazeli, E. Schmidt, R. Bronson, M. Goodell, and R. Weinberg 1992. Effects of an Rb mutation in the mouse. Nature 359: 295–300.
   PubMed Web of Science ®Google Scholar
• Janeway, C., and K. Bottomly 1994. Signals and signs for lymphocyte responses. Cell 76: 275–285.
   PubMed Web of Science ®Google Scholar
• Johnson, D. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11: 1685–1692.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, M. A. Blanar, et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma binding protein with E2F-like properties. Cell 70: 351–364.
   PubMed Web of Science ®Google Scholar
• Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day, B. E. Johnson, and M. H. Skolnick 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440.
   PubMed Web of Science ®Google Scholar
• Kim, K. K., M. H. Soonpaa, H. Wang, and L. J. Field 1995. Developmental expression of p107 mRNA and evidence for alternative splicing of the p107 (RBL1) gene product. Genomics 28: 520–529.
   PubMedGoogle Scholar
• Kruisbeek, A. 1991. Units 4.2.1 and 3.12.1. Current protocols in immunology. In: Coico, R. John Wiley & Sons, New York, N.Y.
   Google Scholar
• Lam, E., J. D. Morris, R. Davies, T. Crook, R. Watson, and K. H. Vousden 1994. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targetting of p107/E2F complexes. EMBO J. 13: 871–878.
   PubMed Web of Science ®Google Scholar
• La Thangue, N. 1994. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell Biol. 6: 443–450.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, and W.-H. Lee 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–295.
   PubMed Web of Science ®Google Scholar
• Lee, M., B. Williams, G. Mulligan, S. Mukai, R. Bronson, N. Dyson, E. Harlow, and T. Jacks 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10: 1621–1632.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., M. Saito, M. Vidal, M. Valentino, T. Look, E. Harlow, N. Dyson, and K. Helin 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813–7825.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and P. Whyte 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7: 2366–2377.
   PubMed Web of Science ®Google Scholar
• Lukas, J., B. O. Petersen, K. Holm, J. Bartek, and K. Helin 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16: 1047–1057.
   PubMed Web of Science ®Google Scholar
• Maandag, E. C. R., M. van der Valk, M. Vlaar, C. Feltkamp, J. O’Brien, M. van Roon, N. van der Lugt, A. Berns, and H. te Riele 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13: 4260–4268.
   PubMed Web of Science ®Google Scholar
• Mayol, X., J. Garriga, and X. Grana 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11: 801–808.
   PubMed Web of Science ®Google Scholar
• Moberg, K., M. A. Starz, and J. A. Lees 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16: 1436–1449.
   PubMed Web of Science ®Google Scholar
• Nevins, J. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424–429.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1994. Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 4: 130–134.
   PubMedGoogle Scholar
• Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. Lee, J. Massague, G. Crabtree, and J. M. Roberts 1994. Interleukin-2-mediated elimination of the p27 kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570–573.
   PubMed Web of Science ®Google Scholar
• Okamoto, A., D. Demetrick, A. Spillare, K. Hagiwara, S. Hussain, W. Bennet, K. Forrester, B. Gerwin, M. Serrano, D. Beach, et al. 1994. Mutations and altered expression of p16INK4A in human cancer. Proc. Natl. Acad. Sci. USA 91: 11045–11049.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., T. Chittenden, D. M. Livingston, Kaelin W., Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6: 953–964.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., D. M. Livingston, Kaelin W., Jr., and P. D. Adams 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918–10922.
   PubMed Web of Science ®Google Scholar
• Rudnicki, M. A., P. Schnegelsberg, R. Stead, T. Braun, H. Arnold, and J. R. Nevins 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351–1359.
   PubMed Web of Science ®Google Scholar
• Sanchez, A., and B. Dynlacht 1996. Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8: 318–324.
   PubMed Web of Science ®Google Scholar
• Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92: 2403–2407.
   PubMedGoogle Scholar
• Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellapan, L. Jakoi, and J. R. Nevins 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12: 1013–1020.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Shin, E. K., A. Shin, C. Pauldin, B. Schaffhausen, and A. Yee 1995. Multiple changes in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15: 2252–2262.
   PubMedGoogle Scholar
• Shirodkar, S. E., M., J. A. DeCaprio, J. Morgan, D. Livingston, and T. Chittenden 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157–166.
   PubMed Web of Science ®Google Scholar
• Smith, E. J., G. Leone, J. Degregori, and J. Nevins 1996. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16: 6965–6976.
   PubMed Web of Science ®Google Scholar
• Starostik, P., K. N. B. Chow, and D. C. Dean 1996. Transcriptional repression and growth suppression by the p107 pocket protein. Mol. Cell. Biol. 16: 3606–3614.
   PubMed Web of Science ®Google Scholar
• Studbal, H., J. Zalvide, K. S. Campbell, C. Schweitzer, T. Roberts, and J. DeCaprio 1997. Inactivation of the RB-related proteins p107 and p130 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17: 4979–4989.
   PubMedGoogle Scholar
• Tivol, E., F. Borriello, A. N. Schweitzer, W. P. Lynch, W. Bluestone, and A. H. Sharpe 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541–547.
   PubMed Web of Science ®Google Scholar
• Tommasi, S., and G. Pfeifer 1995. In vivo structure of the human cdc2 promoter: release of a p130-E2F4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15: 6901–6913.
   PubMedGoogle Scholar
• Vairo, G., D. Livingston, and D. Ginsberg 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9: 869–881.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y., E. S. Knudsen, and P. J. Welch 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64: 25–85.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812–815.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., C. A. Prater, and D. C. Dean 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259–261.
   PubMed Web of Science ®Google Scholar
• Williams, B. O., E. M. Schmitt, L. Remington, R. T. Bronson, D. M. Albert, R. A. Weinberg, and T. Jacks. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J., in press.
   Google Scholar
• Yeager, T., W. Stadler, C. Belair, J. Puthenveettil, O. Olopade, and C. Reznikoff 1995. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res. 55: 493–497.
   PubMed Web of Science ®Google Scholar
• Zalvide, J., and J. A. DeCaprio 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15: 5800–5810.
   PubMedGoogle Scholar
• Zhu, L., G. Enders, J. A. Lees, R. L. Beijersbergen, R. Bernards, and E. Harlow 1995. The pRb-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14: 1904–1913.
   PubMed Web of Science ®Google Scholar
• Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7: 1111–1125.
   PubMed Web of Science ®Google Scholar
• Zuniga-Pflucker, J. C., and M. Lenardo 1996. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8: 215–224.
   PubMed Web of Science ®Google Scholar
• Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Muller 1996. Cell cycle regulation of E2F site occupancy in vivo. Science 271: 1595–1597.
   PubMed Web of Science ®Google Scholar